# Sleep, Depressive Symptoms, and Quality of Life Among Women With Newly Diagnosed Breast Cancer: Baseline Results From the AMBER Cohort Study

## TL;DR

This study finds that sleep problems are linked to lower quality of life in women newly diagnosed with breast cancer, but this link weakens when depressive symptoms are considered.

## Contribution

The study evaluates how depressive symptoms affect the relationship between sleep and quality of life in breast cancer survivors.

## Key findings

- Poor sleep quality was associated with lower physical and mental well-being.
- Adjusting for depressive symptoms reduced the strength of the sleep-quality of life association.
- The association was slightly stronger in women with non-minimal depressive symptoms.

## Abstract

Sleep problems are common among breast cancer survivors and are associated with poor quality of life. However, few studies have considered whether depressive symptoms confound or modify this association. This study evaluates whether depressive symptoms attenuate the association between sleep and quality of life in newly diagnosed breast cancer survivors.

Women with newly diagnosed early‐stage breast cancer were recruited between 2012 and 2019 in Alberta, Canada, and completed the Pittsburg Sleep Quality Index (PSQI) to characterize global sleep quality and subscales. Quality of life was measured using the Short Form Survey (SF‐36 version‐2) to assess physical and mental well‐being. Depressive symptoms were measured using the Patient Health Questionnaire (PHQ‐9). Multivariable linear regressions were used to estimate the association of sleep characteristics with physical and mental well‐being. Depressive symptoms were evaluated as a potential confounder and effect modifier.

Among 1454 breast cancer survivors with available data, 43% reported poor global sleep quality and 10.5% reported clinically meaningful depressive symptoms. Poor sleep quality was associated with lower physical (β = −3.0, 95% CI: −3.8 to −2.3) and mental well‐being (β = −5.7, 95% CI: −6.7 to −4.7). These associations were attenuated to (β = −2.3, 95% CI: −3.1 to 1.5) and (β = −1.2, 95% CI: −2.1 to −0.3) after further adjusting for depressive symptoms. Stratified analyses showed slightly stronger associations in women with non‐minimal depressive symptoms, though this association was not clinically meaningful.

The association between sleep and quality of life was substantially attenuated after accounting for depressive symptoms. Longitudinal data are needed to clarify whether depressive symptoms confound, mediate, or modify this relationship to better guide targeted interventions in breast cancer survivorship.